Banco Bilbao Vizcaya Argentaria, S.A. Abb Vie Inc. Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

$7.82 Billion
Q2 2024

A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 358,987 shares of ABBV stock, worth $72 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

358,987

Previous 354,393 1.3%

Holding current value

$72 Million

Previous $64.5 Million 4.59%

% of portfolio

0.79%

Previous 0.88%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$154.79 - $180.76 $711,105 - $830,411	4,594 Added 1.3%	358,987 $61.6 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $3.59 Million - $4.09 Million	-22,484 Reduced 5.97%	354,393 $64.5 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $113,932 - $128,315	-828 Reduced 0.22%	376,877 $58.4 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $736,882 - $853,049	5,516 Added 1.48%	377,705 $56.3 Million
Q2 2023 Aug 04, 2023	BUY	$132.51 - $164.9 $2.37 Million - $2.95 Million	17,879 Added 5.05%	372,189 $50.1 Million
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $1.68 Million - $1.93 Million	11,589 Added 3.38%	354,310 $56.5 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $1.12 Million - $1.34 Million	-8,073 Reduced 2.3%	342,721 $55.4 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $2.27 Million - $2.61 Million	16,936 Added 5.07%	350,794 $47 Million
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $1.4 Million - $1.78 Million	10,156 Added 3.14%	333,858 $51.1 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $17.3 Million - $21.4 Million	130,751 Added 67.76%	323,702 $52.8 Million
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $4.41 Million - $5.58 Million	41,055 Added 27.03%	192,951 $26.2 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $1.72 Million - $1.95 Million	-16,153 Reduced 9.61%	151,896 $16.5 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $6.3 Million - $7.02 Million	59,897 Added 55.38%	168,049 $18.9 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $2.34 Million - $2.58 Million	22,893 Added 26.85%	108,152 $11.7 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $152,850 - $206,364	-1,899 Reduced 2.18%	85,259 $9.14 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $2.24 Million - $2.63 Million	-26,066 Reduced 23.02%	87,158 $7.63 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $653,726 - $874,783	8,910 Added 8.54%	113,224 $11.1 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $2.81 Million - $4.26 Million	43,530 Added 71.61%	104,314 $7.95 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $4.38 Million - $5.49 Million	60,784 New	60,784 $5.38 Million

Others Institutions Holding ABBV

# of Institutions

3,785

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.

Account

Banco Bilbao Vizcaya Argentaria, S.A. Abb Vie Inc. Transaction History